Published in Hum Mutat on January 01, 2000
Mice with mitochondrial complex I deficiency develop a fatal encephalomyopathy. Cell Metab (2008) 2.72
Mitochondrial complex I: structure, function and pathology. J Inherit Metab Dis (2006) 2.08
Mitochondrial translation and beyond: processes implicated in combined oxidative phosphorylation deficiencies. J Biomed Biotechnol (2010) 2.01
Biochemical diagnosis of mitochondrial disorders. J Inherit Metab Dis (2010) 1.95
NDUFS6 mutations are a novel cause of lethal neonatal mitochondrial complex I deficiency. J Clin Invest (2004) 1.71
Mitochondrial complex I activity suppresses inflammation and enhances bone resorption by shifting macrophage-osteoclast polarization. Cell Metab (2014) 1.65
Mutation of C20orf7 disrupts complex I assembly and causes lethal neonatal mitochondrial disease. Am J Hum Genet (2008) 1.58
Human NADH:ubiquinone oxidoreductase. J Bioenerg Biomembr (2001) 1.40
Isoflurane anesthetic hypersensitivity and progressive respiratory depression in a mouse model with isolated mitochondrial complex I deficiency. J Anesth (2014) 1.40
Large-scale deletion and point mutations of the nuclear NDUFV1 and NDUFS1 genes in mitochondrial complex I deficiency. Am J Hum Genet (2001) 1.36
Mitochondrial genetics. Br Med Bull (2013) 1.30
Multiple oxidative phosphorylation deficiencies in severe childhood multi-system disorders due to polymerase gamma (POLG1) mutations. Eur J Pediatr (2006) 1.29
NDUFA2 complex I mutation leads to Leigh disease. Am J Hum Genet (2008) 1.18
Respiratory chain complex I deficiency caused by mitochondrial DNA mutations. Eur J Hum Genet (2011) 1.14
GeneFriends: an online co-expression analysis tool to identify novel gene targets for aging and complex diseases. BMC Genomics (2012) 1.10
Metallothionein isoform 2A expression is inducible and protects against ROS-mediated cell death in rotenone-treated HeLa cells. Biochem J (2006) 1.08
A novel immunofluorescent assay to investigate oxidative phosphorylation deficiency in mitochondrial myopathy: understanding mechanisms and improving diagnosis. Sci Rep (2015) 1.08
Fatal breathing dysfunction in a mouse model of Leigh syndrome. J Clin Invest (2012) 1.04
Cell cycle re-entry and mitochondrial defects in myc-mediated hypertrophic cardiomyopathy and heart failure. PLoS One (2009) 1.04
Functional consequences of mitochondrial tRNA Trp and tRNA Arg mutations causing combined OXPHOS defects. Eur J Hum Genet (2009) 1.01
Natural disease course and genotype-phenotype correlations in Complex I deficiency caused by nuclear gene defects: what we learned from 130 cases. J Inherit Metab Dis (2012) 0.97
Eukaryotic complex I: functional diversity and experimental systems to unravel the assembly process. Mol Genet Genomics (2008) 0.97
Acetaminophen dosing of humans results in blood transcriptome and metabolome changes consistent with impaired oxidative phosphorylation. Hepatology (2010) 0.95
NDUFA10 mutations cause complex I deficiency in a patient with Leigh disease. Eur J Hum Genet (2010) 0.94
Recurrent acute liver failure and mitochondriopathy in a case of Wolcott-Rallison syndrome. J Inherit Metab Dis (2008) 0.94
Mitochondrial disorders: clinical presentation and diagnostic dilemmas. J Inherit Metab Dis (2003) 0.93
The genetics of Leigh syndrome and its implications for clinical practice and risk management. Appl Clin Genet (2014) 0.93
Protein carbonylation and adipocyte mitochondrial function. J Biol Chem (2012) 0.93
Yeast NDI1 improves oxidative phosphorylation capacity and increases protection against oxidative stress and cell death in cells carrying a Leber's hereditary optic neuropathy mutation. Biochim Biophys Acta (2007) 0.93
The NADH: ubiquinone oxidoreductase (complex I) of the mammalian respiratory chain and the cAMP cascade. J Bioenerg Biomembr (2002) 0.92
The genetics and pathology of mitochondrial disease. J Pathol (2016) 0.92
Leigh syndrome due to compound heterozygosity of dihydrolipoamide dehydrogenase gene mutations. Description of the first E3 splice site mutation. Eur J Pediatr (2003) 0.91
Mitochondrial Oxidative Stress due to Complex I Dysfunction Promotes Fibroblast Activation and Melanoma Cell Invasiveness. J Signal Transduct (2012) 0.90
Mouse models for nuclear DNA-encoded mitochondrial complex I deficiency. J Inherit Metab Dis (2010) 0.90
A novel mutation in NDUFS4 causes Leigh syndrome in an Ashkenazi Jewish family. J Inherit Metab Dis (2008) 0.88
Mechanisms underlying metabolic and neural defects in zebrafish and human multiple acyl-CoA dehydrogenase deficiency (MADD). PLoS One (2009) 0.88
Tissue-specific splicing of an Ndufs6 gene-trap insertion generates a mitochondrial complex I deficiency-specific cardiomyopathy. Proc Natl Acad Sci U S A (2012) 0.88
NUBPL mutations in patients with complex I deficiency and a distinct MRI pattern. Neurology (2013) 0.87
Prerequisites and strategies for prenatal diagnosis of respiratory chain deficiency in chorionic villi. J Inherit Metab Dis (2003) 0.85
Mitochondrial gene therapy improves respiration, biogenesis, and transcription in G11778A Leber's hereditary optic neuropathy and T8993G Leigh's syndrome cells. Hum Gene Ther (2012) 0.85
Progressive cavitating leukoencephalopathy associated with respiratory chain complex I deficiency and a novel mutation in NDUFS1. Neurogenetics (2011) 0.83
A Patient with Complex I Deficiency Caused by a Novel ACAD9 Mutation Not Responding to Riboflavin Treatment. JIMD Rep (2013) 0.83
Region-specific expression of mitochondrial complex I genes during murine brain development. PLoS One (2011) 0.82
Mutated NDUFS6 is the cause of fatal neonatal lactic acidemia in Caucasus Jews. Eur J Hum Genet (2009) 0.82
Mitochondrial disease in childhood: nuclear encoded. Neurotherapeutics (2013) 0.82
The mitochondrial disease associated protein Ndufaf2 is dispensable for Complex-1 assembly but critical for the regulation of oxidative stress. Neurobiol Dis (2013) 0.82
Succinate dehydrogenase deficiency associated with dilated cardiomyopathy and ventricular noncompaction. Eur J Pediatr (2006) 0.82
A forward genetic screen identifies mutants deficient for mitochondrial complex I assembly in Chlamydomonas reinhardtii. Genetics (2011) 0.82
Age modifies respiratory complex I and protein homeostasis in a muscle type-specific manner. Aging Cell (2015) 0.81
Cell-permeable succinate prodrugs bypass mitochondrial complex I deficiency. Nat Commun (2016) 0.79
Succination is Increased on Select Proteins in the Brainstem of the NADH dehydrogenase (ubiquinone) Fe-S protein 4 (Ndufs4) Knockout Mouse, a Model of Leigh Syndrome. Mol Cell Proteomics (2015) 0.79
An update on complex I assembly: the assembly of players. J Bioenerg Biomembr (2014) 0.78
Insights into the pathogenic character of a common NUBPL branch-site mutation associated with mitochondrial disease and complex I deficiency using a yeast model. Dis Model Mech (2013) 0.77
Mitochondrial DNA Heteroplasmy Associations With Neurosensory and Mobility Function in Elderly Adults. J Gerontol A Biol Sci Med Sci (2015) 0.77
Mouse models of mitochondrial complex I dysfunction. Int J Biochem Cell Biol (2012) 0.77
Mitochondrial DNA sequence variation in multiple sclerosis. Neurology (2015) 0.76
Mitochondrial Respiratory Defect Causes Dysfunctional Lactate Turnover via AMP-activated Protein Kinase Activation in Human-induced Pluripotent Stem Cell-derived Hepatocytes. J Biol Chem (2015) 0.76
Glia are critical for the neuropathology of complex I deficiency in Drosophila. Hum Mol Genet (2014) 0.76
Grape seed proanthocyanidins prevent irradiation-induced differentiation of human lung fibroblasts by ameliorating mitochondrial dysfunction. Sci Rep (2017) 0.75
Research on plants for the understanding of diseases of nuclear and mitochondrial origin. J Biomed Biotechnol (2012) 0.75
Metabolic flexibility of mitochondrial respiratory chain disorders predicted by computer modelling. Mitochondrion (2016) 0.75
A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet (1995) 17.27
Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida. Lancet (1995) 5.58
A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects? Am J Hum Genet (1998) 4.96
Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy. Lancet (1999) 3.41
Metronidazole-resistant Helicobacter pylori. Lancet (1990) 3.19
Adverse effects of reverse transcriptase inhibitors: mitochondrial toxicity as common pathway. AIDS (1998) 3.16
Molecular genetic analysis in mild hyperhomocysteinemia: a common mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease. Am J Hum Genet (1996) 2.68
Smith-Lemli-Opitz syndrome is caused by mutations in the 7-dehydrocholesterol reductase gene. Am J Hum Genet (1998) 2.62
Delay in diagnosis of homocystinuria: retrospective study of consecutive patients. BMJ (1996) 2.21
Abnormalities of Gq-mediated cell signaling in Bartter and Gitelman syndromes. Kidney Int (2001) 2.19
Focal segmental glomerulosclerosis in a patient homozygous for a CD2AP mutation. Kidney Int (2007) 1.93
Clinical and molecular genetic characteristics of patients with cerebrotendinous xanthomatosis. Brain (2000) 1.75
Leigh syndrome associated with a mutation in the NDUFS7 (PSST) nuclear encoded subunit of complex I. Ann Neurol (1999) 1.72
Reduction of anionic sites in the glomerular basement membrane by heparanase does not lead to proteinuria. Kidney Int (2007) 1.70
Mutations in the type IV collagen alpha 3 (COL4A3) gene in autosomal recessive Alport syndrome. Hum Mol Genet (1994) 1.69
Novel mutations in the thiazide-sensitive NaCl cotransporter gene in patients with Gitelman syndrome with predominant localization to the C-terminal domain. Kidney Int (1998) 1.66
Conditionally immortalized human glomerular endothelial cells expressing fenestrations in response to VEGF. Kidney Int (2006) 1.60
Genetic characteristics of myoadenylate deaminase deficiency. Ann Neurol (1998) 1.57
Effects of verocytotoxin-1 on nonadherent human monocytes: binding characteristics, protein synthesis, and induction of cytokine release. Blood (1996) 1.51
Congenital muscular dystrophy. J Pediatr (1989) 1.48
The molecular basis of cystathionine beta-synthase deficiency in Dutch patients with homocystinuria: effect of CBS genotype on biochemical and clinical phenotype and on response to treatment. Am J Hum Genet (1999) 1.48
Genotype and phenotype in patients with dihydropyrimidine dehydrogenase deficiency. Hum Genet (1999) 1.48
Mutations in the chloride channel gene CLCNKB as a cause of classic Bartter syndrome. J Am Soc Nephrol (2000) 1.47
A mitochondrial encephalomyopathy: the first case with an established defect at the level of coenzyme Q. Eur J Pediatr (1986) 1.46
Combined enzymatic complex I and III deficiency associated with mutations in the nuclear encoded NDUFS4 gene. Biochem Biophys Res Commun (2000) 1.46
Measurement of cytochromes in human skeletal muscle mitochondria, isolated from fresh and frozen stored muscle specimens. Biochem Med (1978) 1.46
Tyrosine hydroxylase deficiency with severe clinical course: clinical and biochemical investigations and optimization of therapy. J Pediatr (2000) 1.45
Respiratory chain complex I deficiency. Am J Med Genet (2001) 1.42
Defective cystathionine beta-synthase regulation by S-adenosylmethionine in a partially pyridoxine responsive homocystinuria patient. J Clin Invest (1996) 1.42
D-2-Hydroxyglutaric aciduria: biochemical marker or clinical disease entity? Ann Neurol (1999) 1.41
Neonatal De Toni-Debré-Fanconi syndrome due to a defect in complex III of the respiratory chain. Eur J Pediatr (1995) 1.39
Successful treatment of pure myopathy, associated with complex I deficiency, with riboflavin and carnitine. Arch Neurol (1991) 1.39
Dominant isolated renal magnesium loss is caused by misrouting of the Na(+),K(+)-ATPase gamma-subunit. Nat Genet (2000) 1.35
Effects of TNF alpha on verocytotoxin cytotoxicity in purified human glomerular microvascular endothelial cells. Kidney Int (1997) 1.35
Thermolabile methylenetetrahydrofolate reductase in coronary artery disease. Circulation (1997) 1.35
Three different methods for the determination of total homocysteine in plasma. Ann Clin Biochem (1995) 1.30
A new era in the diagnosis and treatment of atypical haemolytic uraemic syndrome. Neth J Med (2012) 1.30
Murine malaria. IV. Disturbed immunological responsiveness during Plasmodium berghei infection. Exp Parasitol (1971) 1.28
Mitochondrial myopathies. Clinical, morphological and biochemical aspects. Eur J Pediatr (1984) 1.28
Enzyme therapy for pompe disease with recombinant human alpha-glucosidase from rabbit milk. J Inherit Metab Dis (2001) 1.25
Altered folate and vitamin B12 metabolism in families with spina bifida offspring. QJM (1997) 1.21
Agrin is a major heparan sulfate proteoglycan in the human glomerular basement membrane. J Histochem Cytochem (1998) 1.20
Molecular genetic analysis of podocyte genes in focal segmental glomerulosclerosis--a review. Eur J Pediatr (2009) 1.19
L-Ornithine-ketoacid-transaminase deficiency in cultured fibroblasts of a patient with hyperornithinaemia and gyrate atrophy of the choroid and retina. Clin Chim Acta (1977) 1.19
A monoclonal antibody against GBM heparan sulfate induces an acute selective proteinuria in rats. Kidney Int (1992) 1.19
Leigh's encephalomyelopathy in a patient with cytochrome c oxidase deficiency in muscle tissue. Pediatrics (1977) 1.18
Spinal xanthomatosis: a variant of cerebrotendinous xanthomatosis. Brain (1999) 1.17
Monocyte chemoattractant protein-1 and interleukin-8 levels in urine and serum of patents with hemolytic uremic syndrome. Pediatr Res (1998) 1.17
Decreased methylene tetrahydrofolate reductase activity due to the 677C-->T mutation in families with spina bifida offspring. J Mol Med (Berl) (1996) 1.17
Influence of cefotaxime on microbial colonization resistance in healthy volunteers. J Antimicrob Chemother (1990) 1.16
Congenital cataract and mitochondrial myopathy of skeletal and heart muscle associated with lactic acidosis after exercise. J Pediatr (1975) 1.15
Impaired prenatal and postnatal growth in Dutch patients with phenylketonuria. The National PKU Steering Committee. Arch Dis Child (1994) 1.14
Cross-reactivity of monoclonal anti-DNA antibodies with heparan sulfate is mediated via bound DNA/histone complexes. J Autoimmun (1990) 1.14
Biochemical studies in the liver and muscle of patients with Zellweger syndrome. Pediatr Res (1983) 1.13
X-linked ataxia, weakness, deafness, and loss of vision in early childhood with a fatal course. Ann Neurol (1993) 1.12
Differential investigation of the capacity of succinate oxidation in human skeletal muscle. Clin Chim Acta (1985) 1.11
Body position can be monitored in 3D using miniature accelerometers and earth-magnetic field sensors. Electroencephalogr Clin Neurophysiol (1998) 1.10
Novel molecular variants of the Na-K-2Cl cotransporter gene are responsible for antenatal Bartter syndrome. Am J Hum Genet (1998) 1.09
Pyruvate oxidation in rat and human skeletal muscle mitochondria. Biochem Med (1978) 1.09
Biochemical hallmarks of tyrosine hydroxylase deficiency. Clin Chem (1998) 1.09
Some practical aspects of providing a diagnostic service for respiratory chain defects. Ann Clin Biochem (2003) 1.09
Simvastatin. A new therapeutic approach for Smith-Lemli-Opitz syndrome. J Lipid Res (2000) 1.09
cDNA of eight nuclear encoded subunits of NADH:ubiquinone oxidoreductase: human complex I cDNA characterization completed. Biochem Biophys Res Commun (1998) 1.08
Human complex I defects can be resolved by monoclonal antibody analysis into distinct subunit assembly patterns. J Biol Chem (2000) 1.08
Investigation of mitochondrial metabolism in small human skeletal muscle biopsy specimens. Improvement of preparation procedure. Clin Chim Acta (1985) 1.08
Distribution of GBM heparan sulfate proteoglycan core protein and side chains in human glomerular diseases. Kidney Int (1993) 1.07
Syndecan-1 deficiency aggravates anti-glomerular basement membrane nephritis. Kidney Int (2007) 1.05
Simvastatin and plasma very-long-chain fatty acids in X-linked adrenoleukodystrophy. Ann Neurol (2000) 1.04
Lethal infantile mitochondrial disease with isolated complex I deficiency in fibroblasts but with combined complex I and IV deficiencies in muscle. Neurology (1996) 1.04
Deficiency of cytochromes b and aa3 in muscle from a floppy infant with cytochrome oxidase deficiency. Eur J Pediatr (1984) 1.03